Table 2 |.
Characteristics | Engineering approach | Reported findings | Limitations | Refs |
---|---|---|---|---|
2D activated T cells | ||||
Immune synapse: T cell-APC interface | Glass-supported planar bilayer with pMHC and an adhesion ligand; ICAM1 for imaging | Immune synapse formation between a T cell and the synthetic surface | Quantitative, qualitative and pattern shape studies cannot be achieved | 171 |
Alternative patterns of GPI-linked pMHC and ICAM1 into a supported lipid bilayer membrane using electron-beam lithography on silica substrates | Chromium barriers enable investigation of basic mechanisms of immunological synapse formation; membrane lipid mobility allows molecular motion in lipid-linked T cell ligands to generate alternatively patterned synapse | Quantitative and qualitative studies cannot be achieved | 86 | |
Aqueous solvent-based photoresist and polyelectrolyte bilayers for printing multi-biotinylated protein arrays | Altered secretion of IL-2 and IFNγ from CD4+ T cells by spatial patterns; PKCθ exhibits aberrant clustering, which resulted in reduced production of IFNγ if patterns of activation sites preclude centralized clustering of TCR ligands | Complex procedure for fabricating multicomponent patterns | 92,172 | |
Selective patterns of the immune synapse generated by incorporating multiple rounds of microcontact printing using a topological PDMS mould | Increased IL-2 and IFNγ production by CD4+ T cells if CD28 receptor clusters are segregated from the cSMAC-localized CD3 receptor and located in the periphery of an artificial immune synapse | Low degree of control over quantity of transferred protein; protein drying process required prior to stamping | 93 | |
Intercellular mechanical forces: T cell-APC interface | Elastomeric PDMS micropillar arrays for regulation of the T cell mechanical force under CD3 and CD28 co-stimulation | CD28 binding increases traction forces associated with CD3 by stimulating a signalling pathway involving PI3K, causing pillar array deformation | Manufacturing process may lead to pillar defects, resulting in low accuracy of intercellular force measurements | 173 |
Polyacrylamide hydrogels (Matrigen) and PDMS micropillars to measure force exertion across the synapse and the kinetics of perforin pore formation in the target cell | CD8+ cell-mediated cytotoxic activity; increased tunnelling of T cells through APC membranes on stiffer substrate; exerted forces across the synapse affect kinetics of perforin pore formation, enhancing cytotoxic capabilities | 2D environment cannot fully capture 3D aspects; therefore, it is unclear whether force exertion is solely responsible for cytotoxic activity | 96 | |
2D germinal centre B cells | ||||
Memory B cell and plasma cell formation | Murine spleen-derived B cells cultured with BALB/c 3T3 fibroblasts expressing CD40 ligand and BAFF in the presence of IL-4 | Induction and expansion of germinal centre B cells; B cell receptor class switching and differentiation into memory B cells; additional culture with IL-21 leads to plasma cell formation | Unaltered immunoglobulin genes in germinal centre B cells after stimulation with IL-21 and CD40L | 123 |
Antigen-specific B cell expansion | Polyvalent presentation of CD40 ligand, complexed with HA peptide, on iron oxide microbeads coated with anti-HA antibody | Expansion of antigen-specific B cells; class switching; germinal centre B cell differentiation in the absence of feeder cells | Influence of microbead properties unknown | 125 |
Antigen-specific B cell responses | Multi-layered lipid vesicles covalently crosslinked and maleimide-functionalized for presentation of malaria antigen | Germinal centre formation; improved strength and breadth of antibody response relative to conventional adjuvants; induction of antigen-specific follicular helper T cells | Unknown whether a wide range of clinically relevant adjuvants, except monophosphoryl lipid A, is effective with lipid vesicle vaccine platform | 174 |
3D artificial APCs | ||||
T cell activation and expansion | Chemically treated bundles of SWNTs embedded with anti-CD3 | Chemical treatment induced surface defects lead to increased anti-CD3 absorption; increased IL-2 release following culture with T cells | Incorporation of stimuli for T cell activation was not explored | 100 |
Carbon nanotube-PLGA composite containing magnetite and IL-2, as a platform for T cell stimuli delivery | Magnetite and IL-2 incorporation increases cytotoxic T cell population through maximizing cell isolation and enrichment; adoptive therapy for murine melanoma by transferring CD8+ T cells delays tumour growth | Difficult to remove carbon nanotube residues from isolated T cells; nanocomposite is cytotoxic | 101 | |
Paramagnetic iron-dextran nanoparticles system for activation and expansion of the naive T cell repertoire | Iron-dextran nanoparticles conjugated with an MHC-immunoglobulin dimer and anti-CD28 increases target T cell population by positive selection from the naive T cell pool, inducing expansion of target cell | Incorporation of multiple signals for T cell expansion not explored; suboptimal T cell expansion | 106 | |
Composite of mesoporous silica microrods and supportive lipid bilayers with soluble IL-2 and anti-T cell receptors | Higher efficiency in polyclonal and antigen-specific T cell expansion than commercial T cell expansion beads; antitumour efficacy in a model of Burkitt’s lymphoma | Density, quantity or spatial distribution of factors for T cell activation cannot be controlled | 102 | |
3D B cell follicle | ||||
Germinal centre B cell differentiation | RGD peptide-functionalized gelatin hydrogel with silicate nanoparticles, splenic B cells from C57BL6 mice and stromal cells presenting CD40 and BAFF; stimulated with IL-4 | Enhanced, rapid B cell proliferation and differentiation, with antibody class switching | B cell responses not antigen-specific | 127 |
Degradable and tuneable maleimide-crosslinked polyethylene glycol hydrogels presenting integrin ligands; seeded with murine splenic B cells and stromal cells presenting CD40 and BAFF; stimulated with IL-4 | Modulation of B cell differentiation; antibody class switching; enrichment of antigen-specific B cells | Additional niche-specific signals required to mimic complexity of germinal centre reactions | 131 |
APC, antigen-presenting cell; BAFF, B cell activating factor; CD40L, CD40 ligand; cSMAC, central supramolecular activation cluster; GPI, glycosylphosphatidylinositol; HA peptide, human influenza haemagglutinin tag (YPYDVPDYA); ICAM1, intercellular adhesion molecule 1; IFNγ, interferon-γ; IL, interleukin; MHC, major histocompatibility complex; PDMS, polydimethylsiloxane; PI3K, phosphoinositide 3-kinase; PKCθ, protein kinase Cθ; PLGA, poly(lactide-co-glycolide); pMHC, peptide-MHC; RGD, Arg-Gly-Asp; SWNT, single-walled carbon nanotube; TCR, T cell receptor.